Anjlee Mahajan, M.D.
Assistant Professor, Division of Hematology and Oncology
To see if Anjlee Mahajan is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
UC Davis Comprehensive Cancer Center
UC Davis Comprehensive Cancer Center
2279 45th Street
Sacramento, CA 95817
Phone: 916-734-5959
UC Davis Midtown Ambulatory Care Center
UC Davis Medical Group - Midtown
3160 Folsom Blvd
Sacramento, CA 95816
Phone: 800-2-UCDAVIS (800-282-3284)
Additional Numbers
Clinic Phone
Clinic Phone
Physician Referrals
Philosophy of Care
I believe it is important to create a trustful and caring relationship with all of my patients. I aim to treat all patients as I would want my own family and friends treated. My goal is to provide you with my own expertise and education to allow you to better make healthcare decisions. I value your trust in me and look forward to partnering to improve your health.
Clinical Interests
Dr. Mahajan is a board certified hematologist and oncologist. She has a clinical and research interest in thrombosis and hemostasis (bleeding disorders). She has expertise in treatment of venous thromboembolism (including deep vein thrombosis and pulmonary embolism) as well as cancer-associated thrombosis.
Research/Academic Interests
Dr. Mahajan's research focuses on using large datasets to explore outcomes in venous thromboembolism, particularly in the area of cancer-associated thrombosis.
Division
Hematology and Oncology
Center/Program Affiliation
Undergraduate School
B.S., Biology, UCLA, Los Angeles CA 2004
Medical School
M.D., Albert Einstein College of Medicine, Bronx NY 2009
Internship
Internal Medicine, UC Davis Medical Center, Sacramento CA 2009-2010
Residency
Internal Medicine, UC Davis Medical Center, Sacramento CA 2010-2012
Fellowship
Hematology and Oncology, UC San Francisco Medical Center, San Francisco CA 2013-2016
Sacramento Magazine Top Doctor Hematology/Oncology, UC Davis Department of Internal Medicine, 2019, 2020
Honorary participant, American Society of Hematology Medical Educator Institute, 2019
American Society of Hematology (ASH) Ambassador Program, 2018, 2019, 2020, 2021
To view a detailed list of Dr. Mahajan's publications, please click here.
Lee A, Oley F Jr, Lo M, Fong R, McGann M, Saunders I, Block S, Mahajan A, Pon TK. Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors. Thromb Res. 2021 Dec;208:148-155. doi:10.1016/j.thromres.2021.10.023. Epub 2021 Oct 29. PMID:34798446.
Mahajan A, Brunson A, Adesina O, Keegan THM, Wun T. The incidence of cancer-associated thrombosis is increasing over time. Blood Adv. 2022 Jan 11;6(1):307-320. doi:10.1182/bloodadvances.2021005590. PMID:34649273.
Mahajan A, White RH. In cancer-related VTE, DOACs reduce recurrent VTE compared with LMWH; groups do not differ for major bleeding. Ann Intern Med. 2020 Dec 15;173(12):JC62. doi:10.7326/ACPJ202012150-062. PMID:33316186.
Poh C, Brunson A, Keegan T, Wun T, Mahajan A. Incidence of Upper Extremity Deep Vein Thrombosis in Acute Leukemia and Effect on Mortality. TH Open. 2020 Oct 28;4(4):e309-e317. doi:10.1055/s-0040-1718883. PMID:33134806.
Hariharan N, Brunson A, Mahajan A, Keegan THM, Wun T. Bleeding in patients with sickle cell disease: a population-based study. Blood Adv. 2020 Mar 10;4(5):793-802. doi:10.1182/bloodadvances.2019000940. PMID:32108229.
Mahajan A, Brunson A, Keegan THM, Rosenberg A, Wun T. High incidence of venous thromboembolism and major bleeding in patients with primary CNS lymphoma. Leuk Lymphoma. 2020 Nov;61(11):2605-2613. doi:10.1080/10428194.2020.1780584. Epub 2020 Jun 23. PMID:32573292.